We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ocular Sciences (OCLR)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul Senior who wrote (30)9/1/2000 11:51:46 AM
From: RWReeves  Read Replies (2) of 36
OCLR is an easy buy for me.

P/E is about 6 trailing. It's 5 if you look at 2001 expected earnings. Steady growth year to year, most recent quarter up 20% or so. Market cap is 250MM, not expensive. This would be an easy one to pick up since it is anti-dilutive. We know it's worth at least 18 since WJ was willing to pay that and I think that's still too cheap. But the WJ deal validates the basics and was only called off as WJ got munched while munching. Food chain. Amazing. Last of the independent CL companies, going for a song.

The wife is an OD and she loves the OCLR lenses which make up the bulk of her fittings.

Problem is not much noise in this, so don't expect a pop until it gets bought. Eventually some dip go-go analyst will stumble across it when (s)he types in the wrong ticker and crow about their great discovery.

We should start a lottery to see who buys this. My guess would be one of the frame makers, who are flush with cash and have bought a LOT dumber things in the past.

As always, omo. Do your own DD-this one is easy to find the numbers and recent history.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext